Cart
sales@molnova.com
BPN14770
CAS No. 1606974-33-7
BPN14770( —— )
Catalog No. M23705 CAS No. 1606974-33-7
BPN14770 is an allosteric inhibitor of selective phosphodiesterase 4D (PDE4D; IC50s: 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 144 | In Stock |
|
| 5MG | 130 | In Stock |
|
| 10MG | 244 | In Stock |
|
| 25MG | 409 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 764 | In Stock |
|
| 200MG | 1004 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBPN14770
-
NoteResearch use only, not for human use.
-
Brief DescriptionBPN14770 is an allosteric inhibitor of selective phosphodiesterase 4D (PDE4D; IC50s: 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3).
-
DescriptionBPN14770 is an allosteric inhibitor of selective phosphodiesterase 4D (PDE4D; IC50s: 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPDE4D3|PDE4D7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1606974-33-7
-
Formula Weight405.8
-
Molecular FormulaC21H15ClF3NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:260 mg/mL (640.71 mM; Need ultrasonic)
-
SMILESOC(Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ricciarelli R, et al. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease. Sci Rep. 2017 Apr 12;7:46320.
molnova catalog
related products
-
N-Acetyl-DL-methioni...
N-acetyl-L-methionine is nutritionally and metabolically equivalent to L-methionine.
-
Adrenocorticotropic ...
Adrenocorticotropic Hormone (ACTH) (4-10) is an agonist of potent melanocortin(MC4R) receptor.In humans, Adrenocorticotropic Hormone (ACTH) (4-10)?enters the cerebral fluid compartment after intranasal application and leads to a?decrease in total body fat after 6 weeks of continuous treatment.
-
C-Type Natriuretic P...
C-Type Natriuretic Peptide, Chicken
